Survival improvements in esophageal and gastric cancers in the Nordic countries favor younger patients

被引:0
|
作者
Hemminki, Kari [1 ,2 ]
Zitricky, Frantisek [1 ]
Foersti, Asta [3 ,4 ]
Hemminki, Otto [5 ,6 ,7 ]
Liska, Vaclav [1 ,8 ]
Hemminki, Akseli [7 ,9 ]
机构
[1] Charles Univ Prague, Fac Med Pilsen, Biomed Ctr, Plzen, Czech Republic
[2] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
[3] Hopp Childrens Canc Ctr KiTZ, Heidelberg, Germany
[4] German Canc Consortium DKTK, Div Pediat Neurooncol, German Canc Res Ctr DKFZ, Heidelberg, Germany
[5] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland
[6] Univ Helsinki, Helsinki, Finland
[7] Univ Helsinki, Translat Immunol Res Program, Canc Gene Therapy Grp, Helsinki, Finland
[8] Charles Univ Prague, Univ Hosp, Fac Med Pilsen, Dept Surg, Plzen, Czech Republic
[9] Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland
来源
CANCER MEDICINE | 2024年 / 13卷 / 15期
关键词
mortality; relative survival; risk factors; stomach cancer; treatment; CLINICAL-PRACTICE GUIDELINE; TRENDS; AGE; REGISTRIES; DIAGNOSIS;
D O I
10.1002/cam4.7365
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Esophageal cancer (EC) and gastric cancer (GC) are fatal cancers with a relatively late age of onset. Age is a negative risk factor for survival in many cancers and our aim was to analyze age-specific survival in EC and GC using the recently updated NORDCAN database. NORDCAN data originate from the Danish, Finnish, Norwegian, and Swedish nationwide cancer registries covering years 1972 through 2021 inviting for comparison of 50-year survival trends between the countries. Relative 1- and 5-year survival and 5/1-year conditional survival (i.e., survival in those who were alive in Year 1 to survive additional 4 years) were analyzed. Survival in EC showed large gains for patients below age 80 years, 5-year survival in Norwegian men reaching 30% and in women over 30% but for 80-89 year old survival remained at 10%. In contrast, hardly any gain was seen among the 80-89 year patients for 1-year survival and small gains in 5 year and 5/1-year survival. Survival gaps between age-groups increased over time. For GC there was also a clear age-related negative survival gradient but the survival gaps between the age groups did not widen over time; Norwegian male and female 5-year survival for 80-89 year old was about 20%. The age-specific survival difference in GC arose in Year 1 and did not essentially increase in 5-year survival. While there were differences in survival improvements between the countries, poor survival of the 80-89 year old patients was shared by all of them. To conclude, survival has improved steadily in younger GC and EC patients in most Nordic countries. While the 80-89 year old population accounts for nearly a quarter of all patients and their poor survival depressed overall survival, which can therefore be increased further by improving diagnostics, treatment and care of elderly EC and GC patients. The data provide up-to-data relative survival data from esophageal and gastric cancers in age-groups. Survival gaps are increasing between young and old patients.image
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Survival in gastric and esophageal cancers in the Nordic countries through a half century
    Hemminki, Kari
    Tichanek, Filip
    Foersti, Asta
    Hemminki, Otto
    Hemminki, Akseli
    CANCER MEDICINE, 2023, 12 (09): : 10212 - 10221
  • [2] Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements
    Hemminki, Kari
    Foersti, Asta
    Liska, Vaclav
    Kanerva, Anna
    Hemminki, Otto
    Hemminki, Akseli
    INTERNATIONAL JOURNAL OF CANCER, 2023, 152 (09) : 1837 - 1846
  • [3] Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers
    Trivers, KF
    De Roos, AJ
    Gammon, MD
    Vaughan, TL
    Risch, HA
    Olshan, AF
    Schoenberg, JB
    Mayne, ST
    Dubrow, R
    Stanford, JL
    Abrahamson, P
    Rotterdam, H
    West, AB
    Fraumeni, JF
    Chow, WH
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (03) : 225 - 230
  • [4] Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
    Tichanek, Filip
    Foersti, Asta
    Hemminki, Otto
    Hemminki, Akseli
    Hemminki, Kari
    OBSTETRICS AND GYNECOLOGY INTERNATIONAL, 2023, 2023
  • [5] Conditional Survival in Prostate Cancer in the Nordic Countries Elucidates the Timing of Improvements
    Zitricky, Frantisek
    Foersti, Asta
    Hemminki, Akseli
    Hemminki, Otto
    Hemminki, Kari
    CANCERS, 2023, 15 (16)
  • [6] Survival trends in solid cancers in the Nordic countries through 50 years
    Hemminki, Janne
    Forsti, Asta
    Hemminki, Akseli
    Hemminki, Kari
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : 77 - 85
  • [7] Long-Term Periodic and Conditional Survival Trends in Prostate, Testicular, and Penile Cancers in the Nordic Countries, Marking Timing of Improvements
    Tichanek, Filip
    Foersti, Asta
    Hemminki, Akseli
    Hemminki, Otto
    Hemminki, Kari
    CANCERS, 2023, 15 (17)
  • [8] Survival in Kidney and Bladder Cancers in Four Nordic Countries through a Half Century
    Tichanek, Filip
    Foersti, Asta
    Hemminki, Akseli
    Hemminki, Otto
    Hemminki, Kari
    CANCERS, 2023, 15 (10)
  • [9] Incidence and survival of esophageal and gastric cancers in BC, Canada.
    Bashash, Morteza
    Shah, Amil
    Hislop, Greg
    Brooks-Wilson, Angela
    Le, Nhu
    Bajdik, Chris
    CANCER RESEARCH, 2008, 68 (09)
  • [10] Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century
    Tichanek, Filip
    Foersti, Asta
    Liska, Vaclav
    Hemminki, Akseli
    Hemminki, Kari
    CANCERS, 2023, 15 (03)